The Bolyaj Prize Foundation Board of Trustees announced Friday that research biologist Katalin Kariko will receive the Bolyai Prize, the most prestigious recognition in Hungarian scientific life, this year, MTI announced. Gabor Sabo, Chairman of the Foundation’s Board of Trustees, said:
Research biologist Katalin Cariko played a leading role in the development of the mRNA-based vaccine against Covid-19, and its results are being monitored worldwide by academia and the general public.
The award ceremony will be held at a later time.
The biennial Bolyai Prize was established in 1998 with the aim of knowledge and science Putting them in a decent place in people’s values, thereby ensuring the social recognition of scholars.
The Foundation Award created on the initiative of civil and private capital can be awarded to persons of Hungarian nationality or of Hungarian origin who achieve outstanding results at the international level in the field of scientific research and development, scientific education of young people and the utilization of their potential. Results in social and economic life.
Katalin Cariko’s work was recently published by It has also been recognized by the joint L’Oréal-UNESCO Prize, which is awarded to female researchers who… they formed Environmental and life sciences.
